A dual-selector biphasic recognition chiral extraction (BRCE) system was developed for the resolution of racemic naproxen using hydrophobic l-di-p-toluoyl-d-tartaric acid (L-DTTA) in the organic phase and hydrophilic hydroxyethyl-β-cyclodextrin (HE-β-CD) in the aqueous phase. Single-selector screening first identified HE-β-CD as the preferred aqueous selector for S-naproxen and L-DTTA as a complementary organic selector for R-naproxen. After optimization of selector concentrations, feed concentration, pH and temperature, the single-stage enantioselectivity yields 2.10, with an enantiomeric excess of 31.93%. Quantum chemical calculations and molecular dynamics simulations were then used to interpret the experimentally verified selectivity trends. The results indicate that HE-β-CD preferentially stabilizes S-naproxen through cavity-size matching and a directional hydrogen-bonding network near the modified cavity entrance, whereas L-DTTA favors R-naproxen through steric complementarity and extensive van der Waals contacts. The opposite recognition preferences of the two selectors generate a cooperative thermodynamic driving force across the oil/water interface. This experimentally validated mechanism provides criteria for selecting dual-phase chiral selectors and designing intensified liquid–liquid extraction systems for enantiomeric separations.
No takes yet. Share an insight, caveat, or question.
Wen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: